This company has been acquired
iCAD Past Earnings Performance
Past criteria checks 0/6
iCAD has been growing earnings at an average annual rate of 26.1%, while the Healthcare Services industry saw earnings growing at 24.8% annually. Revenues have been declining at an average rate of 14.4% per year.
Key information
26.07%
Earnings growth rate
32.10%
EPS growth rate
| Healthcare Services Industry Growth | 1.72% |
| Revenue growth rate | -14.42% |
| Return on equity | -16.98% |
| Net Margin | -26.77% |
| Last Earnings Update | 31 Mar 2025 |
Recent past performance updates
Recent updates
SaaS Transition And AI Partnerships Will Expand Healthcare Reach
Transition to a SaaS business model and strategic partnerships are expected to enhance financial predictability and drive substantial revenue growth.iCAD, Inc. (NASDAQ:ICAD) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
iCAD, Inc. ( NASDAQ:ICAD ) shares have had a horrible month, losing 26% after a relatively good period beforehand...After Leaping 46% iCAD, Inc. (NASDAQ:ICAD) Shares Are Not Flying Under The Radar
The iCAD, Inc. ( NASDAQ:ICAD ) share price has done very well over the last month, posting an excellent gain of 46...iCAD, Inc. (NASDAQ:ICAD) Looks Just Right With A 47% Price Jump
Despite an already strong run, iCAD, Inc. ( NASDAQ:ICAD ) shares have been powering on, with a gain of 47% in the last...iCAD, Inc. (NASDAQ:ICAD) Stock Rockets 26% But Many Are Still Ignoring The Company
iCAD, Inc. ( NASDAQ:ICAD ) shareholders would be excited to see that the share price has had a great month, posting a...iCAD, Inc.'s (NASDAQ:ICAD) P/S Still Appears To Be Reasonable
It's not a stretch to say that iCAD, Inc.'s ( NASDAQ:ICAD ) price-to-sales (or "P/S") ratio of 1.9x right now seems...iCAD, Inc. (NASDAQ:ICAD) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
iCAD, Inc. ( NASDAQ:ICAD ) shareholders would be excited to see that the share price has had a great month, posting a...We're Hopeful That iCAD (NASDAQ:ICAD) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...We Think iCAD (NASDAQ:ICAD) Needs To Drive Business Growth Carefully
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Will iCAD (NASDAQ:ICAD) Spend Its Cash Wisely?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Companies Like iCAD (NASDAQ:ICAD) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...iCAD (NASDAQ:ICAD) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...Revenue & Expenses Breakdown
How iCAD makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 25 | 20 | -5 | 16 | 7 |
| 31 Dec 24 | 20 | -6 | 16 | 7 |
| 30 Sep 24 | 19 | -5 | 16 | 6 |
| 30 Jun 24 | 19 | -5 | 15 | 6 |
| 31 Mar 24 | 18 | -5 | 16 | 5 |
| 31 Dec 23 | 17 | -7 | 17 | 5 |
| 30 Sep 23 | 17 | -9 | 19 | 5 |
| 30 Jun 23 | 18 | -11 | 21 | 5 |
| 31 Mar 23 | 17 | -9 | 20 | 5 |
| 31 Dec 22 | 20 | -10 | 21 | 5 |
| 30 Sep 22 | 23 | -12 | 23 | 7 |
| 30 Jun 22 | 28 | -11 | 24 | 8 |
| 31 Mar 22 | 33 | -13 | 26 | 9 |
| 31 Dec 21 | 34 | -11 | 26 | 9 |
| 30 Sep 21 | 36 | -9 | 25 | 9 |
| 30 Jun 21 | 34 | -8 | 23 | 8 |
| 31 Mar 21 | 32 | -7 | 22 | 8 |
| 31 Dec 20 | 30 | -18 | 22 | 8 |
| 30 Sep 20 | 29 | -19 | 22 | 8 |
| 30 Jun 20 | 29 | -21 | 23 | 9 |
| 31 Mar 20 | 31 | -22 | 23 | 9 |
| 31 Dec 19 | 31 | -14 | 21 | 9 |
| 30 Sep 19 | 29 | -14 | 19 | 9 |
| 30 Jun 19 | 27 | -12 | 18 | 8 |
| 31 Mar 19 | 26 | -9 | 16 | 8 |
| 31 Dec 18 | 26 | -9 | 16 | 9 |
| 30 Sep 18 | 27 | -10 | 16 | 10 |
| 30 Jun 18 | 27 | -15 | 16 | 10 |
| 31 Mar 18 | 28 | -17 | 18 | 10 |
| 31 Dec 17 | 28 | -14 | 18 | 9 |
| 30 Sep 17 | 27 | -13 | 19 | 10 |
| 30 Jun 17 | 26 | -9 | 19 | 10 |
| 31 Mar 17 | 27 | -8 | 19 | 10 |
| 31 Dec 16 | 26 | -10 | 18 | 10 |
| 30 Sep 16 | 27 | -9 | 18 | 9 |
| 30 Jun 16 | 31 | -7 | 19 | 9 |
| 31 Mar 16 | 34 | -33 | 20 | 9 |
| 31 Dec 15 | 42 | -32 | 21 | 9 |
| 30 Sep 15 | 48 | -30 | 22 | 9 |
| 30 Jun 15 | 50 | -29 | 23 | 9 |
| 31 Mar 15 | 49 | -3 | 22 | 9 |
| 31 Dec 14 | 44 | -1 | 21 | 8 |
| 30 Sep 14 | 39 | -5 | 20 | 8 |
Quality Earnings: ICAD is currently unprofitable.
Growing Profit Margin: ICAD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ICAD is unprofitable, but has reduced losses over the past 5 years at a rate of 26.1% per year.
Accelerating Growth: Unable to compare ICAD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ICAD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (9.2%).
Return on Equity
High ROE: ICAD has a negative Return on Equity (-16.98%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/18 19:22 |
| End of Day Share Price | 2025/07/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iCAD, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew D'Silva | B. Riley Securities, Inc. |
| Matthew Scalo | Canaccord Genuity |
| David Turkaly | Citizens JMP Securities, LLC |